Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZBio1 in Patients With Gout
NCT07752810Phase 2Completed
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical Inc.
- Start
- Jun 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 2 trial of HZBio1 in gout, sponsored by Hangzhou Grand Biologic Pharmaceutical Inc.. Started Jun 2022; status: completed.
02
Drugs
HZBio1
03
Conditions
gout
Beyond the preview
Go deeper on NCT07752810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07752810.